Patents by Inventor Elena Baixeras Llano

Elena Baixeras Llano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220313620
    Abstract: This invention relates to the delivery of a composition, preferably a pharmaceutical composition, comprising D-pinitol, D-Chiro inositol or myo-inositol or any pharmaceutically acceptable salt thereof, for use in the treatment or prevention of disorders, diseases or conditions responsive to the stimulation of the ghrelin receptor in a subject in need thereof.
    Type: Application
    Filed: September 9, 2020
    Publication date: October 6, 2022
    Inventors: Fernando RODRIGUEZ DE FONSECA, Juan Antonio NAVARRO GALERA, Elena BAIXERAS LLANO, Juan Manuel DECARA DEL OLMO, Dina MEDINA VERA, Antonio Jesús LÓPEZ GAMBERO, Juan SUAREZ PEREZ, Carlos SANJUAN MERINO, Cristina ROSELL DEL VALLE, Francisco Javier PAVÓN MORÓN
  • Patent number: 7732397
    Abstract: Use of cardiotrophin in liver diseases. The invention describes the increased expression of cardiotrophin (CT-1) during the process of hepatic regeneration coinciding with maximum proliferation of hepatocytes and the role of CT-1 as a stimulator of hepatic regeneration. Furthermore, it describes the hepatoprotective role of CT-1 in various models of acute liver damage. The importance of using CT-1 in the manufacture of compositions for use in the treatment of hepatopathies is demonstrated. The invention describes such use in various forms and methods, including the recombinant protein and the use of the gene sequences that code for CT-1.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: June 8, 2010
    Assignee: Proyecto de Biomedicina Cima, S.L.
    Inventors: Matilde Bustos De Abajo, Jesús Prieto Valtueña, Juan José Lasarte Sagastibelza, Elena Baixeras Llano
  • Publication number: 20040224888
    Abstract: Use of cardiotrophin in liver diseases. The invention describes the increased expression of cardiotrophin (CT-1) during the process of hepatic regeneration coinciding with maximum proliferation of hepatocytes and the role of CT-1 as a stimulator of hepatic regeneration. Furthermore, it describes the hepatoprotective role of CT-1 in various models of acute liver damage.
    Type: Application
    Filed: March 11, 2004
    Publication date: November 11, 2004
    Applicant: FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
    Inventors: Matilde Bustos De Abajo, Jesus Prieto Valtuena, Juan Jose Lasarte Sagastibelza, Elena Baixeras Llano